It's a new steroid-free topical cream that ... Systemic biologic psoriasis treatments These are newer drugs made from living organisms. Biologics are divided into groups: tumor necrosis factor ...

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

The following is a summary of “Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis ...

A research group has made significant progress in investigating the therapeutic effects and molecular mechanisms of ...

Discover a recent randomised clinical trial that evaluated the efficacy of a new monoclonal antibody to treat plaque ...

AbbVie’s psoriasis drug risankizumab ... as the company prepares to file the drug with global regulators. An interleukin-23 inhibitor, risankizumab is one of a group of new drugs that AbbVie ...

Continued application of the drug prevented excess cell growth—the ultimate goal of psoriasis treatment. The research team plans to further tweak the benzamil molecule, hoping to produce an even ...

AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s ...

This attack causes your body to produce new skin ... scalp psoriasis can feel like a heavy burden on you, especially when you always have to treat it with OTC or prescription medications.

This treatment may have fewer side effects than many medications ... Anyone with new or worsening symptoms of scalp psoriasis should ask their doctor about the options available.

As per this new study by Fact.MR, the global psoriasis drug market is estimated at a valuation ... from the United States FDA for Otezla to treat mild to moderate plaque psoriasis in adults.

Approximately 60–70% of patients that do not benefit from standard nonbiologic treatments ... is a new member in the anti-TNF-α family. Phase II studies for plaque psoriasis showed convincing ...